The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rykov M.Iu.

Nauchno-issledovatel'skiĭ institut detskoĭ onkologii i gematologii Rossiĭskogo onkologicheskogo nauchnogo tsentra im. N.N. Blokhina RAMN, Moskva

Buĭdenok Iu.V.

Nauchno-issledovatel'skiĭ institut detskoĭ onkologii i gematologii Rossiĭskogo onkologicheskogo nauchnogo tsentra im. N.N. Blokhina RAMN, Moskva

The optimal venous access for the chemotherapy in children

Authors:

Rykov M.Iu., Buĭdenok Iu.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2012;(9): 60‑63

Views: 601

Downloaded: 10

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Rykov MIu, Buĭdenok IuV. The optimal venous access for the chemotherapy in children. Pirogov Russian Journal of Surgery. 2012;(9):60‑63. (In Russ.)

Подписка 2025 (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Opti­mal prevention of VTE in cancer surgery patients with impaired renal function. Piro­gov Russian Journal of Surgery. 2024;(1):119-126
Approaches to the diagnosis and treatment of patients with stage III—IV non-small cell lung cancer in Russia. Preliminary resu­lts of a prospective multicenter non-interventional obse­rvational study KARL. P.A. Herzen Journal of Onco­logy. 2023;(6):33-37
Use of Atezolizumab in patients with adva­nced small cell lung cancer. P.A. Herzen Journal of Onco­logy. 2023;(6):63-67
The role of pharmacogenomics in personalized treatment of onco­logical diseases. P.A. Herzen Journal of Onco­logy. 2023;(6):75-81
Modern operative gyne­cology in geriatric patients. Russian Journal of Human Reproduction. 2024;(1):10-25
Fertility-sparing treatment in cancer patients: how can we help in the 21st century?. Russian Journal of Human Reproduction. 2024;(1):26-63
Correction of anemia and mito­chondrial dysfunction by iron citrate «Sintezit» during neoadjuvant chemotherapy for colo­rectal cancer and lymphoproliferative diso­rders. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):21-31
Gona­dotropin-releasing hormone agonists as a chance for motherhood in the future. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):30-36
Colo­rectal cancer and gut microbiota. P.A. Herzen Journal of Onco­logy. 2024;(2):60-66
Unco­ntrolled inhi­bition of checkpoints. P.A. Herzen Journal of Onco­logy. 2024;(2):67-73

The optimal choice for the long-term venous access for children is a full implanted venous port systems. We own the experience of 87 port implantations to children aged from 6 months to 17 years with various oncological disease. The experience was successful in all cases but one, where the septic inflammation of the subcutaneous pocket developed.

Keywords:

oncology
chemotherapy
venous port-systems
venous acces

Authors:

Rykov M.Iu.

Nauchno-issledovatel'skiĭ institut detskoĭ onkologii i gematologii Rossiĭskogo onkologicheskogo nauchnogo tsentra im. N.N. Blokhina RAMN, Moskva

Buĭdenok Iu.V.

Nauchno-issledovatel'skiĭ institut detskoĭ onkologii i gematologii Rossiĭskogo onkologicheskogo nauchnogo tsentra im. N.N. Blokhina RAMN, Moskva

List of references:

  1. Buidenok Yu.V., Meshcheryakov A.A. Implantiruemye port-sistemy venoznogo dostupa v onkologii. Vestn intens terapii 2004; 3: 3-8.
  2. Galt'eri I., Deppe I., Siperli M., Tomson D. Kateterizatsiya podklyuchichnoi veny: ul'trazvukovoi kontrol' pozvolyaet menee opytnym vracham dobit'sya luchshikh rezul'tatov. Vestn intens terapii 2006; 4: 24-30.
  3. Egiev V.N., Shchetinin V.V., Trofimenko Yu.G. Polnost'yu implantiruemye sistemy v meditsine. M: Medpraktika-M 2004; 60.
  4. Sukhorukov V.P., Berdikyan A.S., Epshtein S.L. Punktsiya i kateterizatsiya ven. Traditsionnye i novye tekhnologii. Posobie dlya vrachei. Sankt-Peterburgskoe meditsinskoe izdatel'stvo 2001; 55.
  5. Blenkharn J.I. In vitro antibacterial activity of noxythiolin and taurolidine. J Pharm Pharmacol 1990; 42: 589-590.
  6. Browne M.K., Leslie G.B., Pfirrmann R.W. Taurolin, a new chemothera peutic agent. J Appl Bacteriol 1976; 41: 363-368.
  7. Browne M.K. Pharmacological and clinical studies with Taurolin®. In: Bruckner W.L., Pfirrman R.W.R., editors. Proceedings of the International Taurolin Symposium 1985.
  8. Calabresi P., Goulette F.A., Darnowski J.W. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent. Cancer Res 2001; 61: 6816-6821.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.